טוען...
Metabotropic glutamate receptors: Targets for neuroprotective therapies in Parkinson disease
Metabotropic glutamate receptors (mGluRs) are heavily expressed throughout the basal ganglia (BG), where they modulate neuronal excitability, transmitter release and long term synaptic plasticity. Therefore, targeting specific mGluR subtypes by means of selective drugs could be a possible strategy f...
שמור ב:
| הוצא לאור ב: | Curr Opin Pharmacol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5949090/ https://ncbi.nlm.nih.gov/pubmed/29605730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2018.03.004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|